Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo. Taking semaglutide while pregnant is not recommended. UK guidance is clear: Wegovy and other semaglutide medicines should be stopped before conception and are not used during pregnancy or breastfeeding. If you discover you are pregnant while on semaglutide, stop the medicine and speak to your GP or midwife promptly. This page covers what the evidence says, what to do next, and how to plan safely if weight management remains a priority after pregnancy.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks is whether it's safe to take a short break from semaglutide during the first trimester and then resume. The answer, based on current UK guidance, is no — not during any part of pregnancy, and not during breastfeeding either. Semaglutide is a prescription-only medicine with a pharmacological half-life of roughly one week. That means it remains active in the body for several weeks after the last dose, which is precisely why guidance exists around stopping it before trying to conceive, not simply on the day of a positive test.
The concern isn't theoretical. Animal studies conducted during development identified developmental toxicity at doses relevant to human therapeutic exposure. Robust controlled trials in pregnant humans have not been conducted (they cannot ethically be) so the absence of human harm data is not reassurance; it is uncertainty. The NHS semaglutide medicines page states explicitly that semaglutide should not be taken during pregnancy. That position reflects the summary of product characteristics and the current scientific consensus.
Stopping promptly if you discover a pregnancy is the right move. The semaglutide already in your system will clear over several weeks; that is not something you can speed up. Your GP or midwife can help monitor the early weeks and discuss next steps.
Current advice goes further than simply avoiding semaglutide during pregnancy. Women of childbearing potential are advised to use effective contraception throughout treatment. There is a particular nuance worth knowing if you are on tirzepatide rather than semaglutide, but for semaglutide specifically, NHS guidance does not flag a reduced pill-absorption effect in the same way. Regardless, reliable contraception throughout treatment is the standard clinical expectation.
How long before trying to conceive should you stop? Prescribers generally advise stopping with enough lead time for the medicine to clear the body. Given semaglutide's half-life, a window of at least two months before attempting conception is a commonly discussed minimum, though your prescriber will give you personalised advice based on your situation. If you have questions about whether you can be on semaglutide while pregnant, our dedicated page covers the clinical position in full. You can read more about semaglutide's licensed use for weight management on our Wegovy overview page.
If weight management remains a health priority in the period before pregnancy, a conversation with your GP or a specialist about lifestyle-based approaches is the appropriate route. GLP-1 medicines are not part of that picture.
Finding out you are pregnant while on semaglutide can be alarming, but acting calmly and quickly is what matters. Stop taking the medicine. Contact your GP or midwife and tell them you have been taking semaglutide; they will note this in your maternity record and can discuss monitoring. Most prescribers will also want to be informed so your record is updated and your prescription is suspended.
The existing evidence does not definitively establish what, if any, risk a short inadvertent exposure creates in humans. Animal data showed developmental effects, but translating animal toxicology to human pregnancy outcomes is not straightforward. What is clear is that continuing is not appropriate. The MHRA Drug Safety Update process exists precisely to communicate new safety signals as post-marketing data accumulates; if new evidence on inadvertent pregnancy exposure emerges, it will appear there.
If you want to understand more about the difference between Wegovy and other branded semaglutide medicines while you work through this, our page addressing whether you can use Wegovy while pregnant covers the branded context in more detail.
For many people, the reason they were prescribed semaglutide in the first place (managing a weight-related health condition) does not disappear when they decide to start a family. This is worth discussing openly with your GP well before you start trying to conceive, so there is a clear plan: when to stop, how to maintain progress in the interim, and when it might be appropriate to restart after pregnancy and breastfeeding have concluded.
Restarting after breastfeeding is finished is clinically possible, subject to a fresh assessment of your health at that point. A new prescription will require a new clinical review. At nume, every prescription (including repeat requests) is reviewed by a GPhC-registered prescriber before it is issued, so there is no automatic restart; your situation at the time is what the assessment considers.
If you are not pregnant but are exploring your options for weight management and want to understand what is currently available and clinically appropriate, the weight-loss treatments page outlines the consultation process. For wider context on Wegovy specifically in pregnancy, or on where Wegovy can be obtained through a regulated route, those pages are there when you need them. Straightforward advice, no pressure.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.